{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:39:07Z","timestamp":1767994747613,"version":"3.49.0"},"reference-count":17,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T00:00:00Z","timestamp":1454803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_raon-2016-0002_s_001_w2aab3b8b5b1b7b1aab1c15b1Aa\">\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>To assess the technical and clinical outcome of percutaneous insertion of tunneled peritoneal catheters in the palliative treatment of refractory malignant ascites and to determine the safety and feasibility of intraperitoneal administration of cytotoxic drugs through the tunneled catheter.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_raon-2016-0002_s_002_w2aab3b8b5b1b7b1aab1c15b2Aa\">\n                  <jats:title>Materials and methods<\/jats:title>\n                  <jats:p>Consecutive patients palliatively treated with a tunneled peritoneal catheter to drain the malignant ascites were identified. Patients\u2019 medical history, procedural and clinical follow-up data, including complications and estimated survival, were reviewed. Additionally, a sub analysis of the patients with widespread ovarian cancer and refractory ascites treated with or without intraperitoneal administration of cytotoxic drugs was made.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_raon-2016-0002_s_003_w2aab3b8b5b1b7b1aab1c15b3Aa\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In all 94 patients it was technically feasible to insert the peritoneal drainage catheter and to drain a median of 3260 cc (range 100 cc \u2013 8500 cc) of malignant ascitic fluid. Post procedural complications included catheter infection (n = 2; 2%), fluid leakage around the entry site (n = 4; 4%), catheter occlusion (n = 2; 2%), sleeve formation around the catheter tip (n = 1; 1%) and accidental loss of the catheter (n = 1; 1%). There was no increase in catheter infection rate in patients treated with or without intraperitoneal administration of cytotoxic drugs. Median overall survival after catheter insertion is 1.7 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_raon-2016-0002_s_004_w2aab3b8b5b1b7b1aab1c15b4Aa\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Percutaneous insertion of a tunneled Tenckhoff catheter for the palliative drainage of malignant ascites and intraperitoneal infusion of cytotoxic drugs is feasible and associated with a very low complication rate, including catheter infection. These tunneled peritoneal lines are beneficial for symptomatic palliative treatment of refractory ascites and allow safe intraperitoneal chemotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/raon-2016-0002","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T08:12:35Z","timestamp":1524211955000},"page":"197-203","source":"Crossref","is-referenced-by-count":24,"title":["Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome"],"prefix":"10.1515","volume":"50","author":[{"given":"Geert","family":"Maleux","sequence":"first","affiliation":[{"name":"Department of Radiology, University Hospitals Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Indesteege","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Hospitals Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and and Statistical Bioinformatics, KU Leuven and Universiteit Hasselt, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Verslype","sequence":"additional","affiliation":[{"name":"Department of Digestive Oncology, University Hospitals Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, University Hospitals Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Prenen","sequence":"additional","affiliation":[{"name":"Department of Digestive Oncology, University Hospitals Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,2,7]]},"reference":[{"key":"2021040712105352325_j_raon-2016-0002_ref_001_w2aab3b8b5b1b7b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"Mullard A, Bishop J, Jibani M. Intractable malignant ascites: An alternative management option. J Palliative Med 2011; 2: 251\u20133.","DOI":"10.1089\/jpm.2010.0196"},{"key":"2021040712105352325_j_raon-2016-0002_ref_002_w2aab3b8b5b1b7b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"O\u2019Neill M, Weissleder R, Gervais D, Hahn P, Mueller P. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. Am J Roentgenol 2001; 177: 615\u20138.","DOI":"10.2214\/ajr.177.3.1770615"},{"key":"2021040712105352325_j_raon-2016-0002_ref_003_w2aab3b8b5b1b7b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Richard H, Coldwell D, Boyd-Kranis R, Murthy R, Van Echo D. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Intervent Radiol 2001: 12: 373\u20135.","DOI":"10.1016\/S1051-0443(07)61919-8"},{"key":"2021040712105352325_j_raon-2016-0002_ref_004_w2aab3b8b5b1b7b1ab2ab4Aa","unstructured":"Belfort M, Stevens P, DeHaek K, Soeters R, Krige J. A new approach to the management of malignant ascites; a permanently implanted abdominal drain. Eur J Surg Oncol 1990; 16: 47\u201353."},{"key":"2021040712105352325_j_raon-2016-0002_ref_005_w2aab3b8b5b1b7b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"Arai Y, Inaba Y, Sone M, Saitoh H, Takeuchi Y, Shioyama Y, et al. Plase I\/ II study of transjugular transhepatic peritoneovenous venous shunt, a new procedure to manage refractory ascites in cancer patients: Japan Interventional Radiology in Oncology Study Group 0201. Am J Roentgenol 2011; 196: W621\u2013W626.","DOI":"10.2214\/AJR.10.4716"},{"key":"2021040712105352325_j_raon-2016-0002_ref_006_w2aab3b8b5b1b7b1ab2ab6Aa","doi-asserted-by":"crossref","unstructured":"Lorentzen T, Sengel\u00f8v L, Nols\u00f8e CP, Khattar SC, Karstrup S, von der Maase H. Ultrasonically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol 1995; 36:481\u20134.","DOI":"10.1177\/028418519503600434"},{"key":"2021040712105352325_j_raon-2016-0002_ref_007_w2aab3b8b5b1b7b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Stehman F, Ehrlich C. Peritoneo-cystic shunt for malignant ascites. Gynecol Oncol 1984; 18: 402\u20137.","DOI":"10.1016\/0090-8258(84)90052-0"},{"key":"2021040712105352325_j_raon-2016-0002_ref_008_w2aab3b8b5b1b7b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"Rosenberg S, Courtney A, Nemcek A, Omary R. Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Intervent Radiol 2004; 15: 1129\u201331.","DOI":"10.1097\/01.RVI.0000136828.42612.B4"},{"key":"2021040712105352325_j_raon-2016-0002_ref_009_w2aab3b8b5b1b7b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Tapping C, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol 2012; 85: 623\u20138.","DOI":"10.1259\/bjr\/24538524"},{"key":"2021040712105352325_j_raon-2016-0002_ref_010_w2aab3b8b5b1b7b1ab2ac10Aa","doi-asserted-by":"crossref","unstructured":"Lungren M, Kim C, Stewart J, Smith T, Miller M. Tunneled peritoneal drainage catheter placement for refractory ascites: Single-center experience in 188 patients. J Vasc Intervent Radiol 2014; 24: 1303\u20138.","DOI":"10.1016\/j.jvir.2013.05.042"},{"key":"2021040712105352325_j_raon-2016-0002_ref_011_w2aab3b8b5b1b7b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Courtney A, Nemcek A, Rosenberg S, Tutton S, Darcy M, Gordon G. Prospective evaluation of the PleurX catheter when used to treat malignant ascites associated with malignancy. J Vasc Intervent Radiol 2008; 19: 1723\u201331.","DOI":"10.1016\/j.jvir.2008.09.002"},{"key":"2021040712105352325_j_raon-2016-0002_ref_012_w2aab3b8b5b1b7b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"Savin M, Kirsch M, Romano W, Wang S, Arpasi P, Mazon C. Peritoneal ports for treatment of intractable ascites. J Vasc Intervent Radiol 2005; 16: 363\u20138.","DOI":"10.1097\/01.RVI.0000147082.05392.2B"},{"key":"2021040712105352325_j_raon-2016-0002_ref_013_w2aab3b8b5b1b7b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"Ozkan O, Akinci D, Gocmen R, Cil B, Ozmen M, Akhan O. Percutaneous placement of peritoneal port-catheter in patients with malignant ascites. Cardiovasc Intervent Radiol 2007; 30: 232\u20136.","DOI":"10.1007\/s00270-005-0252-4"},{"key":"2021040712105352325_j_raon-2016-0002_ref_014_w2aab3b8b5b1b7b1ab2ac14Aa","doi-asserted-by":"crossref","unstructured":"Baumann K, Pfisterer J, Wimberger P, Burchardi N, Kurzeder C, du Bois A, et al. Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group. Gynecol Oncol 2011; 123: 27\u201332.","DOI":"10.1016\/j.ygyno.2011.06.004"},{"key":"2021040712105352325_j_raon-2016-0002_ref_015_w2aab3b8b5b1b7b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"Barnett T, Rubins J. Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: A simplified percutaneous approach. J Vasc Intervent Radiol 2002; 13: 379\u201383.","DOI":"10.1016\/S1051-0443(07)61740-0"},{"key":"2021040712105352325_j_raon-2016-0002_ref_016_w2aab3b8b5b1b7b1ab2ac16Aa","doi-asserted-by":"crossref","unstructured":"Akinci D, Erol B, Ciftci T, Akhan O. Radiologically placed tunneled peritoneal catheter in palliation of malignant ascites. Eur J Radiol 2008; 80: 265\u20138.","DOI":"10.1016\/j.ejrad.2010.06.047"},{"key":"2021040712105352325_j_raon-2016-0002_ref_017_w2aab3b8b5b1b7b1ab2ac17Aa","doi-asserted-by":"crossref","unstructured":"Heiss M, Murawa P, Koralewski P, Kutarska E, Kolesnik O, Ivanchenko V, et al. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II\/III trial. Int J Cancer 2010; 127: 2209\u201321.","DOI":"10.1002\/ijc.25423"}],"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/raon.2016.50.issue-2\/raon-2016-0002\/raon-2016-0002.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/raon-2016-0002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T01:03:28Z","timestamp":1617843808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/raon-2016-0002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,7]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,7]]},"published-print":{"date-parts":[[2016,6,1]]}},"alternative-id":["10.1515\/raon-2016-0002"],"URL":"https:\/\/doi.org\/10.1515\/raon-2016-0002","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,7]]}}}